Analyst Ratings for NovaBay Pharmaceuticals (nby)

nby Rating Summary

  |   Expand Research on nby
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 6.7 / 10   Percentile Rank: 74%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/7/2016 Maxim Group Downgrade Hold
(Buy)
N/A
(N/A)
0.10 2.34 2240% Details
3/6/2013 Ascendiant Capital New Coverage Strong Buy
(N/A)
2.25
(N/A)
1.15 2.34 103.48% Details
Like NBY Ratings? Also take a look at SRI, ZLTQ, CAH, MCK

NBY Ratings News